Johnson & Johnson learned of “unexplained illness” in Phase 3 coronavirus trial

Johnson & Johnson said Tuesday that it learned of the “unexplained illness,” which caused it to pause its Phase 3 coronavirus vaccine trial in the US, on Sunday and immediately informed the Data and Safety Monitoring Board, or DSMB, which monitors clinical trial developments. Pročitaj više